Login / Signup

New Advances in Evaluation of Hearing in a Sample of Egyptian Children with β-Thalassemia Major.

Fatma A AlzareeManal A ShehataMohamed Abdel AttiGihan A ElzareeGhada M El-Kassas
Published in: Open access Macedonian journal of medical sciences (2019)
Hearing loss is prevailing in patients with β-thalassemia major on iron chelating agents. Therefore, regular hearing evaluations and periodic check-ups after the initiation of chelation therapy are mandatory.
Keyphrases
  • hearing loss
  • sickle cell disease
  • young adults